Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Imaging Studies III: Computed Tomography01:27

Imaging Studies III: Computed Tomography

52
DefinitionComputed Tomography (CT) of the genitourinary (GU) tract is a non-invasive imaging modality that utilizes X-rays and computer processing to generate detailed cross-sectional images of the urinary system, encompassing the kidneys, ureters, bladder, and adjacent structures such as the adrenal glands.PurposeCT scans of the GU tract serve several diagnostic and therapeutic purposes, including:Diagnosis of Urinary Tract Diseases: Detects kidney stones, tumors, cysts, and congenital...
52
Nursing Assessment of the Genitourinary System I: Health History01:21

Nursing Assessment of the Genitourinary System I: Health History

77
The genitourinary system is critical to maintaining fluid balance, waste elimination, and reproductive function. Nurses play a vital role in assessing this system, beginning with a thorough health history. This process involves gathering patient information, identifying risk factors, and recognizing symptoms of genitourinary disorders. Early detection is vital for timely interventions and management.1. Gathering Patient InformationA complete health history includes the patient’s personal,...
77
Imaging Studies I: Kidney, Ureter, and Bladder Studies01:28

Imaging Studies I: Kidney, Ureter, and Bladder Studies

41
Kidney, Ureter, and Bladder (KUB) StudiesKidney, Ureter, and Bladder (KUB) studies are standard diagnostic imaging procedures used to assess the anatomy of the urinary system. They are commonly utilized for patients experiencing abdominal pain or urinary symptoms. By using a simple X-ray of the abdomen, KUB studies can reveal structural and pathological abnormalities within the kidneys, ureters, and bladder. These studies are particularly valuable in diagnosing kidney stones, urinary...
41
Imaging Studies IV: Magnetic Resonance Imaging01:27

Imaging Studies IV: Magnetic Resonance Imaging

53
Introduction:Magnetic Resonance Imaging, or MRI, can include a specialized imaging technique of the urinary system known as Magnetic Resonance Urography (MRU). This radiation-free technique uses strong magnetic fields and radio waves to produce detailed images with the help of a computer. MRU is particularly effective for visualizing fluid-filled structures like the kidneys, ureters, and bladder.Applications of MRI in the Genitourinary SystemKidneys and Ureters: MRI detects tumors, cysts,...
53
Biological Effects of Radiation02:59

Biological Effects of Radiation

16.0K
All radioactive nuclides emit high-energy particles or electromagnetic waves. When this radiation encounters living cells, it can cause heating, break chemical bonds, or ionize molecules. The most serious biological damage results when these radioactive emissions fragment or ionize molecules. For example, α and β particles emitted from nuclear decay reactions possess much higher energies than ordinary chemical bond energies. When these particles strike and penetrate matter, they...
16.0K
Imaging Studies II: Ultrasonography01:24

Imaging Studies II: Ultrasonography

57
IntroductionUltrasonography, or renal ultrasound, is a noninvasive medical imaging technique that uses high-frequency sound waves to visualize the kidneys, ureters, bladder, and surrounding tissues.Indications for Urinary System UltrasonographyUrinary system ultrasonography is indicated in various clinical scenarios, such as:Kidney Stones (Urolithiasis): To detect and monitor the size and presence of kidney or urinary tract stones.Hydronephrosis: To assess the dilation of the renal pelvis and...
57

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Quality of Life After Postprostatectomy Radiotherapy: A TROG 08.03 RAVES Randomized Controlled Trial Substudy.

European urology oncology·2026
Same author

Dynamic immune profiling predicts response to radiation plus anti-PD-1 therapy in oligometastatic renal cell carcinoma.

Nature communications·2026
Same author

Is there an association between acute, subacute, and late genitourinary quality of life with prostate SBRT boost?

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026
Same author

Evaluation of mid-treatment <sup>18</sup>F-FDG PET changes in the oral cavity as a predictor of radiation-induced mucositis severity.

Quantitative imaging in medicine and surgery·2026
Same author

Building an Interoperable Rare Disease Multi-omic Resource: The GREGoR Data Model and Dataset.

bioRxiv : the preprint server for biology·2026
Same author

Unusual Cause of Pain and Extensive Leg Swelling in a Teenage Girl.

Pediatrics in review·2026

Related Experiment Video

Updated: Sep 13, 2025

Stereotactic Radiosurgery for Gynecologic Cancer
10:35

Stereotactic Radiosurgery for Gynecologic Cancer

Published on: April 17, 2012

18.3K

Dosimetric Clues to Addressing Urinary Toxicity Following Stereotactic Prostate Radiation Therapy.

Michael Cardoso1,2, Matthew Richardson3, Phillip Chlap1,2,4

  • 1Liverpool and Macarthur Cancer Therapy Centres, Sydney, Australia.

Advances in Radiation Oncology
|August 1, 2025
PubMed
Summary

Stereotactic body radiation therapy (SBRT) for prostate cancer can cause genitourinary (GU) toxicity. Bladder and urethral radiation dose are key predictors, with prior transurethral resection of the prostate (TURP) also increasing risk.

More Related Videos

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods
09:49

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods

Published on: April 24, 2020

10.1K
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.5K

Related Experiment Videos

Last Updated: Sep 13, 2025

Stereotactic Radiosurgery for Gynecologic Cancer
10:35

Stereotactic Radiosurgery for Gynecologic Cancer

Published on: April 17, 2012

18.3K
A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods
09:49

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods

Published on: April 24, 2020

10.1K
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.5K

Area of Science:

  • Radiation Oncology
  • Urology
  • Medical Physics

Background:

  • Delayed genitourinary (GU) toxicity occurs in 15-30% of patients after definitive stereotactic body radiation therapy (SBRT) for prostate cancer.
  • Understanding the relationship between radiation dose to the bladder and urethra and GU toxicity is crucial for improving patient outcomes.

Purpose of the Study:

  • To investigate the association between radiation dose delivered to the bladder and urethra and the incidence of grade ≥ 2 GU toxicity.
  • To identify specific dose-volume parameters predictive of GU toxicity following prostate SBRT.

Main Methods:

  • Analysis of a phase 2 multicenter trial (PROST-EBRT) involving SBRT boost for prostate cancer.
  • Correlation of bladder and urethral planning organ at risk volume (PRV) dosimetry with physician-reported GU toxicity (≥ 6 months post-SBRT).
  • Univariate and multivariate analyses were performed, including an examination of prior transurethral resection of the prostate (TURP).

Main Results:

  • Of 87 patients with complete data, 19.5% experienced grade ≥ 2 GU toxicity.
  • Prostatic urethral length, urethral PRV volume, and bladder dose-volume parameters (D2 cc, D5 cc, D10 cc, D15 cc, V8) were predictive on univariate analysis.
  • Prior TURP was associated with significantly higher GU toxicity (43% vs. 15%). Multivariate analysis identified urethral length, urethral PRV volume, bladder D10 cc, and D15 cc as significant predictors.

Conclusions:

  • Prostate SBRT as a virtual high-dose-rate boost is generally well-tolerated, but a notable minority experience delayed GU toxicity.
  • Implementing stricter bladder constraints (D10 cc < 17 Gy, D15 cc < 15 Gy) may further mitigate GU toxicity risk.
  • Prior TURP is a potential risk factor for increased urinary toxicity after prostate SBRT.